drugset / Trial / NCT06944132
CsA vs MMC for Preventing Pterygium Recurrence
RandomizedParallel-groupOpen-labelTreatment
Summary
aimed to compare the efficacy and safety of topical cyclosporin A (CsA) versus mitomycin C (MMC) as adjunctive therapies in preventing pterygium recurrence after surgical excision.
Timeline
- Start
- 2024-04-01
- Primary completion
- 2024-09-30
- Completion
- 2024-10-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cyclosporine | Peptide | 0.05 % | Topical |
| Subject | Mitomycin C | Other / unclassified | 0.02 % | Topical |